Ticlon 2mg (Eszopiclone) is primarily prescribed for the treatment of insomnia, a condition characterized by difficulty falling asleep, staying asleep throughout the night, or waking up too early in the morning. It helps improve sleep patterns and is the first sedative approved for long-term use in managing chronic insomnia.
Ticlon 2mg (Eszopiclone) acts on the GABA (gamma-aminobutyric acid) receptor complexes. These receptors play a crucial role in inhibiting brain activity, which induces relaxation and sleep. Eszopiclone binds to specific allosteric sites near or functionally linked to benzodiazepine receptors, enhancing the calming effects of GABA and leading to sedation. Unlike benzodiazepines, it is classified as a non-benzodiazepine hypnotic, making it effective for improving sleep while having a potentially lower risk of dependency.
Ticlon 2mg is generally well-tolerated, but some individuals may experience side effects. These can be categorized as common, less common, and serious side effects.
Ticlon 2mg has sedative effects, and certain substances can intensify drowsiness or lead to excessive sedation, including:
Ticlon 2mg is not recommended for individuals with the following conditions:
There is limited clinical data on the effects of an overdose of Ticlon 2mg. However, in clinical trials, a case of overdose with up to 36 mg of Eszopiclone was reported, and the patient fully recovered.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.